Quarterly report pursuant to Section 13 or 15(d)

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail)

v3.20.2
Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Mar. 31, 2020
[2]
Sep. 30, 2019
Jun. 30, 2019
[2]
Mar. 31, 2019
[2]
Sep. 30, 2020
Sep. 30, 2019
Schedule Of Cash Flow Supplemental [Line Items]              
Cash paid for interest           $ 53,364 $ 56,326
Cash paid (refunds received) for income taxes, net           (108,776) 69,498
Noncash investing and financing activities:              
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [1]           (7,933) (13,642)
Investment in NCM – receipt of common units (see Note 9)           3,620 1,552
Dividends accrued on unvested restricted stock unit awards   $ (256) $ (189) [2] $ (189) $ (108) (257) (486)
NCM              
Noncash investing and financing activities:              
Interest expense - NCM (see Note 9) $ (5,901)   $ (4,666)     $ (17,726) $ (14,180)
[1] Additions to theatre properties and equipment included in accounts payable as of September 30, 2020 and December 31, 2019 were $7,058 and $14,991, respectively.
[2] Below is a summary of dividends paid to stockholders as well as dividends accrued on unvested restricted stock units during the nine months ended September 30, 2020 and 2019